157 related articles for article (PubMed ID: 20156976)
1. Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases.
Hervier B; Wallaert B; Hachulla E; Adoue D; Lauque D; Audrain M; Camara B; Fournie B; Couret B; Hatron PY; Dubucquoi S; Hamidou M
Rheumatology (Oxford); 2010 May; 49(5):972-6. PubMed ID: 20156976
[TBL] [Abstract][Full Text] [Related]
2. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Dominique S; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Tiev KP; Vittecoq O; Noel D; Mouthon L; Menard JF; Jouen F
Autoimmun Rev; 2012 Aug; 11(10):739-45. PubMed ID: 22326685
[TBL] [Abstract][Full Text] [Related]
3. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
Wilkes MR; Sereika SM; Fertig N; Lucas MR; Oddis CV
Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
[TBL] [Abstract][Full Text] [Related]
4. [Two cases of interstitial pneumonia with anti-PL-12 (alanyl tRNA synthetase) antibodies].
Satoh S; Hirakata M; Suwa A; Mimori T; Inada S; Akizuki M
Ryumachi; 1996 Dec; 36(6):862-8. PubMed ID: 9122826
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody to PL-12 (Anti-Alanyl-tRNA synthetase) in an African American girl with juvenile dermatomyositis and resolution of interstitial lung disease.
Vega P; Ibarra M; Prestridge A; Pachman LM
J Rheumatol; 2011 Feb; 38(2):394-5. PubMed ID: 21285181
[No Abstract] [Full Text] [Related]
6. Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias.
Watanabe K; Handa T; Tanizawa K; Hosono Y; Taguchi Y; Noma S; Kobashi Y; Kubo T; Aihara K; Chin K; Nagai S; Mimori T; Mishima M
Respir Med; 2011 Aug; 105(8):1238-47. PubMed ID: 21514811
[TBL] [Abstract][Full Text] [Related]
7. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.
Hervier B; Devilliers H; Stanciu R; Meyer A; Uzunhan Y; Masseau A; Dubucquoi S; Hatron PY; Musset L; Wallaert B; Nunes H; Maisonobe T; Olsson NO; Adoue D; Arlet P; Sibilia J; Guiguet M; Lauque D; Amoura Z; Hachulla E; Hamidou M; Benveniste O
Autoimmun Rev; 2012 Dec; 12(2):210-7. PubMed ID: 22771754
[TBL] [Abstract][Full Text] [Related]
8. Painful myositis in the anti-synthetase syndrome with anti-PL12 antibodies.
Mehta P; Patel L; Roncaroli F; Pickering MC; Brand A
Rheumatol Int; 2012 Mar; 32(3):825-7. PubMed ID: 21328057
[No Abstract] [Full Text] [Related]
9. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase).
Targoff IN; Arnett FC
Am J Med; 1990 Mar; 88(3):241-51. PubMed ID: 2178410
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis.
Bunn CC; Bernstein RM; Mathews MB
J Exp Med; 1986 May; 163(5):1281-91. PubMed ID: 3701255
[TBL] [Abstract][Full Text] [Related]
11. Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody.
Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF; Levesque H; Jouen F
Semin Arthritis Rheum; 2012 Jun; 41(6):890-9. PubMed ID: 22078416
[TBL] [Abstract][Full Text] [Related]
12. Outcome of anti-PL12 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Dominique S; Landron C; Roblot P; Jouneau S; Vittecoq O; Jouen F
Presse Med; 2013 Jun; 42(6 Pt 1):e153-8. PubMed ID: 23428662
[TBL] [Abstract][Full Text] [Related]
13. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series.
Giannini M; Notarnicola A; Dastmalchi M; Lundberg IE; Lopalco G; Iannone F
Clin Rheumatol; 2016 Sep; 35(9):2363-7. PubMed ID: 27068736
[TBL] [Abstract][Full Text] [Related]
15. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia.
Betteridge Z; Gunawardena H; North J; Slinn J; McHugh N
Rheumatology (Oxford); 2007 Jun; 46(6):1005-8. PubMed ID: 17392287
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies.
Sato S; Kuwana M; Hirakata M
Rheumatology (Oxford); 2007 May; 46(5):842-5. PubMed ID: 17255133
[TBL] [Abstract][Full Text] [Related]
17. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
Yoshifuji H; Fujii T; Kobayashi S; Imura Y; Fujita Y; Kawabata D; Usui T; Tanaka M; Nagai S; Umehara H; Mimori T
Autoimmunity; 2006 May; 39(3):233-41. PubMed ID: 16769657
[TBL] [Abstract][Full Text] [Related]
18. [Two cases of polymyositis associated with interstitial pneumonia with anti-OJ (isoleucyl tRNA synthetase) antibodies].
Satoh S; Hirakata M; Nakamura K; Kuwana M; Ohosone Y; Matsuoka Y; Irimajiri S; Fukuda J; Kuramochi S; Mimori T; Ikeda Y
Ryumachi; 1998 Jun; 38(3):534-41. PubMed ID: 9721563
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Pathologic Manifestations of Anti-Alanyl-tRNA Synthetase (Anti-PL-12)-Related Inflammatory Myopathy.
Schneider F; Yousem SA; Oddis CV; Aggarwal R
Arch Pathol Lab Med; 2018 Feb; 142(2):191-197. PubMed ID: 28967806
[TBL] [Abstract][Full Text] [Related]
20. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease.
Hirakata M; Suwa A; Nagai S; Kron MA; Trieu EP; Mimori T; Akizuki M; Targoff IN
J Immunol; 1999 Feb; 162(4):2315-20. PubMed ID: 9973509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
